Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Leder

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Theoretical Population Biology|May 22, 2010
Evolutionary dynamics of tumor progression with random fitness valuesRick Durrett, Jasmine Foo, Kevin Leder, et al.
Plos One|December 6, 2011
Fitness conferred by BCR-ABL kinase domain mutations determines the risk of pre-existing resistance in chronic myeloid leukemiaKevin Leder, Jasmine Foo, Brian Skaggs, et al.
Plos Computational Biology|September 18, 2015
An Evolutionary Approach for Identifying Driver Mutations in Colorectal CancerJasmine Foo, Lin L Liu, Kevin Leder, et al.
JCO Clinical Cancer Informatics|February 14, 2019
Glioblastoma Recurrence and the Role of O<sup>6</sup>-Methylguanine-DNA Methyltransferase Promoter MethylationKatie Storey, Kevin Leder, Andrea Hawkins-Daarud, et al.
Molecular Pharmaceutics|October 15, 2011
Evolutionary modeling of combination treatment strategies to overcome resistance to tyrosine kinase inhibitors in non-small cell lung cancerShannon M Mumenthaler, Jasmine Foo, Kevin Leder, et al.
Cell|February 4, 2014
Mathematical modeling of PDGF-driven glioblastoma reveals optimized radiation dosing schedulesKevin Leder, Ken Pitter, Quincey LaPlant, et al.
Cancer Informatics|August 6, 2015
The Impact of Microenvironmental Heterogeneity on the Evolution of Drug Resistance in Cancer CellsShannon M Mumenthaler, Jasmine Foo, Nathan C Choi, et al.
Plos Computational Biology|March 6, 2024
Using birth-death processes to infer tumor subpopulation structure from live-cell imaging drug screening dataChenyu Wu, Einar Bjarki Gunnarsson, Even Moa Myklebust, et al.
Cell Reports Methods|April 14, 2023
Phenotypic deconvolution in heterogeneous cancer cell populations using drug-screening dataAlvaro Köhn-Luque, Even Moa Myklebust, Dagim Shiferaw Tadele, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Theoretical Population Biology|May 22, 2010
Evolutionary dynamics of tumor progression with random fitness valuesRick Durrett, Jasmine Foo, Kevin Leder, et al.
Plos One|December 6, 2011
Fitness conferred by BCR-ABL kinase domain mutations determines the risk of pre-existing resistance in chronic myeloid leukemiaKevin Leder, Jasmine Foo, Brian Skaggs, et al.
Plos Computational Biology|September 18, 2015
An Evolutionary Approach for Identifying Driver Mutations in Colorectal CancerJasmine Foo, Lin L Liu, Kevin Leder, et al.
JCO Clinical Cancer Informatics|February 14, 2019
Glioblastoma Recurrence and the Role of O<sup>6</sup>-Methylguanine-DNA Methyltransferase Promoter MethylationKatie Storey, Kevin Leder, Andrea Hawkins-Daarud, et al.
Molecular Pharmaceutics|October 15, 2011
Evolutionary modeling of combination treatment strategies to overcome resistance to tyrosine kinase inhibitors in non-small cell lung cancerShannon M Mumenthaler, Jasmine Foo, Kevin Leder, et al.
Cell|February 4, 2014
Mathematical modeling of PDGF-driven glioblastoma reveals optimized radiation dosing schedulesKevin Leder, Ken Pitter, Quincey LaPlant, et al.
Cancer Informatics|August 6, 2015
The Impact of Microenvironmental Heterogeneity on the Evolution of Drug Resistance in Cancer CellsShannon M Mumenthaler, Jasmine Foo, Nathan C Choi, et al.
Plos Computational Biology|March 6, 2024
Using birth-death processes to infer tumor subpopulation structure from live-cell imaging drug screening dataChenyu Wu, Einar Bjarki Gunnarsson, Even Moa Myklebust, et al.
Cell Reports Methods|April 14, 2023
Phenotypic deconvolution in heterogeneous cancer cell populations using drug-screening dataAlvaro Köhn-Luque, Even Moa Myklebust, Dagim Shiferaw Tadele, et al.
Pageof 3